The epidemiological signature of influenza B virus and its B/Victoria and B/Yamagata lineages in the 21st century

We describe the epidemiological characteristics, pattern of circulation, and geographical distribution of influenza B viruses and its lineages using data from the Global Influenza B Study. We included over 1.8 million influenza cases occurred in thirty-one countries during 2000–2018. We calculated the proportion of cases caused by influenza B and its lineages; determined the timing of influenza A and B epidemics; compared the age distribution of B/Victoria and B/Yamagata cases; and evaluated the frequency of lineage-level mismatch for the trivalent vaccine. The median proportion of influenza cases caused by influenza B virus was 23.4%, with a tendency (borderline statistical significance, p = 0.060) to be higher in tropical vs. temperate countries. Influenza B was the dominant virus type in about one every seven seasons. In temperate countries, influenza B epidemics occurred on average three weeks later than influenza A epidemics; no consistent pattern emerged in the tropics. The two B lineages caused a comparable proportion of influenza B cases globally, however the B/Yamagata was more frequent in temperate countries, and the B/Victoria in the tropics (p = 0.048). B/Yamagata patients were significantly older than B/Victoria patients in almost all countries. A lineage-level vaccine mismatch was observed in over 40% of seasons in temperate countries and in 30% of seasons in the tropics. The type B virus caused a substantial proportion of influenza infections globally in the 21st century, and its two virus lineages differed in terms of age and geographical distribution of patients. These findings will help inform health policy decisions aiming to reduce disease burden associated with seasonal influenza.

[1]  M. L. Matute,et al.  Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014 , 2018, BMC Infectious Diseases.

[2]  M. Kretzschmar,et al.  Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[3]  A. Melidou,et al.  Dominant influenza A(H3N2) and B/Yamagata virus circulation in EU/EEA, 2016/17 and 2017/18 seasons, respectively , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[4]  I. Barr,et al.  Literature review of the epidemiology of influenza B disease in 15 countries in the Asia‐Pacific region , 2018, Influenza and other respiratory viruses.

[5]  M. Postma,et al.  The cost-effectiveness of trivalent and quadrivalent influenza vaccination in communities in South Africa, Vietnam and Australia , 2018, Vaccine.

[6]  F. Schellevis,et al.  Important changes in the timing of influenza epidemics in the WHO European Region over the past 20 years: virological surveillance 1996 to 2016 , 2018, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  S. Raboni,et al.  Molecular epidemiology of influenza B virus and implications in immunization strategy, Southern Brazil. , 2018, Vaccine.

[8]  J. Bresee,et al.  Advances in measuring influenza burden of disease , 2018, Influenza and other respiratory viruses.

[9]  Ivo M Foppa,et al.  Annual estimates of the burden of seasonal influenza in the United States: A tool for strengthening influenza surveillance and preparedness , 2018, Influenza and other respiratory viruses.

[10]  Jan Kyncl,et al.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study , 2017, The Lancet.

[11]  Wladimir J Alonso,et al.  The spatiotemporal characteristics of influenza A and B in the WHO European Region: can one define influenza transmission zones in Europe? , 2017, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  S. Madhi,et al.  Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014 , 2017, PloS one.

[13]  M. Postma,et al.  A systematic review of the health economic consequences of quadrivalent influenza vaccination , 2017, Expert review of pharmacoeconomics & outcomes research.

[14]  Heidi L. Tessmer,et al.  Estimating the Lineage Dynamics of Human Influenza B Viruses , 2016, PloS one.

[15]  C. Macintyre,et al.  Epidemiology of influenza B in Australia: 2001‐2014 influenza seasons , 2016, Influenza and other respiratory viruses.

[16]  K. Vandemaele,et al.  Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics – a systematic literature review , 2016, Influenza and other respiratory viruses.

[17]  M. L. Matute,et al.  Temporal Patterns of Influenza A and B in Tropical and Temperate Countries: What Are the Lessons for Influenza Vaccination? , 2016, PloS one.

[18]  Marije Vonk Noordegraaf-Schouten,et al.  A comprehensive review of the epidemiology and disease burden of Influenza B in 9 European countries , 2016, Human vaccines & immunotherapeutics.

[19]  I. Barr,et al.  Differential age susceptibility to influenza B/Victoria lineage viruses in the 2015 Australian influenza season. , 2016, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[20]  H. Vennema,et al.  Early occurrence of influenza A epidemics coincided with changes in occurrence of other respiratory virus infections , 2015, Influenza and other respiratory viruses.

[21]  S. Cui,et al.  Epidemiological and Phylogenetic Characteristics of Influenza B Infection in Severe Acute Respiratory Infection Cases in Beijing, 2014 to 2015 , 2015, Medicine.

[22]  R. Colindres,et al.  Patterns of influenza B circulation in Brazil and its relevance to seasonal vaccine composition , 2015, The Brazilian Journal of Infectious Diseases.

[23]  Pham Th,et al.  Circulation of influenza B lineages in northern Viet Nam, 2007-2014. , 2015 .

[24]  B. Cowling,et al.  Comparative Epidemiology of Influenza B Yamagata- and Victoria-Lineage Viruses in Households. , 2015, American journal of epidemiology.

[25]  B. Lina,et al.  Ten influenza seasons in France: distribution and timing of influenza A and B circulation, 2003–2013 , 2015, BMC Infectious Diseases.

[26]  L. Brammer,et al.  Epidemiological and virological characteristics of influenza B: results of the Global Influenza B Study , 2015, Influenza and Other Respiratory Viruses.

[27]  James M. McCaw,et al.  Interval Between Infections and Viral Hierarchy Are Determinants of Viral Interference Following Influenza Virus Infection in a Ferret Model , 2015, The Journal of infectious diseases.

[28]  Timothy B. Stockwell,et al.  The contrasting phylodynamics of human influenza B viruses , 2015, eLife.

[29]  K. Prosenc,et al.  A comparison of the demographic and clinical characteristics of laboratory-confirmed influenza B Yamagata and Victoria lineage infection. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[30]  T. Heikkinen,et al.  Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  John Steel,et al.  Roles of Humidity and Temperature in Shaping Influenza Seasonality , 2014, Journal of Virology.

[32]  T. Carvalhanas,et al.  Evolutionary pattern of reemerging influenza B/Victoria lineage viruses in São Paulo, Brazil, 1996–2012: Implications for vaccine composition strategy , 2013, Journal of medical virology.

[33]  Mark Loeb,et al.  Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis , 2013, BMJ.

[34]  C. Bauch,et al.  Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis , 2013, BMC Medicine.

[35]  C. Viboud,et al.  Environmental Predictors of Seasonal Influenza Epidemics across Temperate and Tropical Climates , 2013, PLoS pathogens.

[36]  J. Oxford,et al.  The burden of influenza B: a structured literature review. , 2013, American journal of public health.

[37]  Wladimir J Alonso,et al.  EPIPOI: A user-friendly analytical tool for the extraction and visualization of temporal parameters from epidemiological time series , 2012, BMC Public Health.

[38]  D. Skowronski,et al.  Influenza B/Victoria Antigen Induces Strong Recall of B/Yamagata But Lower B/Victoria Response in Children Primed With Two Doses of B/Yamagata , 2011, The Pediatric infectious disease journal.

[39]  R. Belshe,et al.  Efficacy of live attenuated influenza vaccine in children against influenza B viruses by lineage and antigenic similarity. , 2010, Vaccine.

[40]  A. Kendal,et al.  Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. , 1990, Virology.

[41]  Q. M. Le,et al.  Circulation of influenza B lineages in northern Viet Nam, 2007-2014. , 2015, Western Pacific surveillance and response journal : WPSAR.